Skip to main content
SpringerLink
Log in

Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The specific features of interactions between megakaryocytic and granulocytic hematopoiesis lineages and myelofibrosis were studied in patients with active phase (before treatment) of chronic myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma. In patients with chronic myeloid leukemia, a direct correlation was found between the severity of both early and advanced myelofibrosis and the number of megakaryocytes in the bone marrow irrespectively of the type of the bone marrow tumor. The parameters of granulocytic hematopoiesis lineage were higher in myelofibrosis. In patients with chronic lymphocytic leukemia and multiple myeloma, negative correlations between the severity of early and advanced myelofibrosis and the number of megakaryocytes in the bone marrow and platelets in the peripheral blood were found. In chronic lymphocytic leukemia, negative correlations between the severity of early and advanced myelofibrosis and the number of neutrophils in the bone marrow and peripheral blood were detected. In patients with multiple myeloma, negative correlations between the severity of advanced myelofibrosis and number of neutrophils in the bone marrow and peripheral blood were detected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Artyukhina ZE, Semenova NYu, Balashova VA, Bessmel’tsev SS, Rugal’ BI. Hematopoietic tissue and stromal microenvironment in patients with multiple myeloma. Vestn. Gematol. 2017;13(1):15-18. Russian.

  2. Dolgikh TYu, Kachesov IV, Marchenko AA, Domnikova NP. Clinical and pathomorphological examination of myelofibrosis in chronic myeloid leukemia. Sib. Onkol. Zh. 2015;(6):39-45. Russian.

  3. Domnikova NP, Dolgikh TYu. Prevalence of myelofibrosis in chronic myeloid leukemia, multiple myeloma and chronic lymphocytic leukemia in different phases of diseases. Sib. Nauch. Med. Zh. 2016;36(5):53-57. Russian.

  4. Programmed treatment of the blood system diseases. Savchenko VG, ed. Handbook of Diagnostic Algorithms and Protocols of Treatment of Blood System Diseases: in 2 vol. Moscow, 2012. Vol. 2. Russian.

  5. Russian Clinical Guidelines for the Diagnosis and Treatment of Lymphoproliferative Diseases. Poddubnaya IV, Savchenko VG, eds. Moscow, 2016. Russian.

  6. Semenova NYu, Bessmel’tsev SS, Gritsaev SV, Voloshin SV, Rugal’ VI. The state of structures of the hematopoietic niche in malignized B-lymphopoiesis. Vestn. Gematol. 2018;14(1):4- 11. Russian.

  7. Timchenko AS, Zalessky VN. Bone marrow fibrosis - the basis of mielofibrosis: pathogenesis, prognostication and antifibrogenic targeted strategies. Med. Perspektivi. 2018;23(1):121- 133. Russian.

  8. Usenova AA. Modern aspects of molecular-genetic researchers of hemoblastosis. Vestn. Kyrgyz.-Ross. Slav. Univer. 2017;17(10):169-171. Russian.

  9. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ; International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111(12):5446-5456. https://doi.org/10.1182/blood-2007-06-093906

  10. Khonglah Y, Basu D, Dutta TK. Bone marrow trephine biopsy findings in chronic myeloid leukemia. Malays. J. Pathol. 2002;24(1):37-43.

    PubMed  Google Scholar 

  11. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3-9. https://doi.org/10.1038/leu.2008.291

    Article  CAS  PubMed  Google Scholar 

  12. Lauta VM. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer. 2003;97(10):2440-2452.

    Article  CAS  Google Scholar 

  13. Rumi E, Passamonti F, Bernasconi P, Arcaini L, Pietra D, Elena C, Boveri E, Pascutto C, Cazzola M, Lazzarino M. Validation of cytogenetic-based risk stratification in primary myelofibrosis. Blood. 2010;115(13):2719-2720. https://doi.org/10.1182/blood-2009-12-258988

    Article  CAS  PubMed  Google Scholar 

  14. Subramanian R, Basu D, Dutta TK. Prognostic significance of bone marrow histology in multiple myeloma. Indian J. Cancer. 2009;46(1):40-45.

    Article  CAS  Google Scholar 

  15. Tadmor T, Shvidel L, Aviv A, Ruchlemer R, Bairey O, Yuklea M, Herishanu Y, Braester A, Rahimi-Levene N, Vernea F, Ben- Ezra J, Bejar J, Polliack A; Israeli CLL Study Group. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications. Cancer. 2013;119(10):1853-1859. https://doi.org/10.1002/cncr.27930

Download references

Author information

Authors and Affiliations

  1. Institute of Molecular Pathology and Pathomorphology, Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia

    T. Yu. Dolgikh, S. R. Senchukova, E. V. Vinogradova & Yu. M. Krinitsyna

Authors
  1. T. Yu. Dolgikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. R. Senchukova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. V. Vinogradova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu. M. Krinitsyna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Yu. Dolgikh.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 168, No. 12, pp. 692-697, December, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolgikh, T.Y., Senchukova, S.R., Vinogradova, E.V. et al. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma. Bull Exp Biol Med 168, 734–738 (2020). https://doi.org/10.1007/s10517-020-04791-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-04791-z

Key Words

Search

Navigation